← SynDRA
Lmk-235
SynDRA canonical compound SYN1299216 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | HDAC4 | HDAC5 |
| Mechanism of action | HDAC inhibitor |
Drug classes
- Histone Deacetylase Inhibitors
Cross-references
Synonyms
- RefChem:823110
- N-((6-(hydroxyamino)-6-oxohexyl)oxy)-3,5-dimethylbenzamide
- N-[6-(hydroxyamino)-6-oxohexoxy]-3,5-dimethylbenzamide
- MFCD26522892
- LMK235
- N-[[6-(Hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl-benzamide
- N-[6-(hydroxyamino)-6-oxo-hexoxy]-3,5-dimethyl-benzamide
- 6-{[(3,5-dimethylphenyl)formamido]oxy}-N-hydroxyhexanamide
- orb1301108
- SCHEMBL17160822
- GLXC-03900
- EX-A1115
- LMK-235?
- BDBM50424996
- s7569
- AKOS024458368
- CCG-267411
- CS-5250
- FH90205
- NCGC00379210-02
- NCGC00379210-03
- AC-32653
- AS-55928
- BP-40069
- DA-33434
- HY-18998
- T6061
- L493400
Look up Lmk-235 in the interactive SynDRA portal →